» Articles » PMID: 23065369

Management of Hyperglycemia During Enteral and Parenteral Nutrition Therapy

Overview
Journal Curr Diab Rep
Publisher Current Science
Specialty Endocrinology
Date 2012 Oct 16
PMID 23065369
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperglycemia is a frequent complication of enteral and parenteral nutrition in hospitalized patients. Extensive evidence from observational studies indicates that the development of hyperglycemia during parenteral and enteral nutrition is associated with an increased risk of death and infectious complications. There are no specific guidelines recommending glycemic targets and effective strategies for the management of hyperglycemia during specialized nutritional support. Managing hyperglycemia in these patients should include optimization of carbohydrate content and administration of intravenous or subcutaneous insulin therapy. The administration of continuous insulin infusion and insulin addition to nutrition bag are efficient approaches to control hyperglycemia during parenteral nutrition. Subcutaneous administration of long-acting insulin with scheduled or corrective doses of short-acting insulin is superior to the sliding scale insulin strategy in patients receiving enteral feedings. Randomized controlled studies are needed to evaluate safe and effective therapeutic strategies for the management of hyperglycemia in patients receiving nutritional support.

Citing Articles

Tolerability of Sodium-Glucose Co-transporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Retrospective Cohort Study.

Radi S, Almutairi M, Alghamdi A, Alzahrani M, Alghamdi S, Almalky N Cureus. 2025; 16(12):e75798.

PMID: 39816301 PMC: 11734641. DOI: 10.7759/cureus.75798.


Continuous glucose monitoring in adults with short bowel syndrome receiving overnight infusions of home parenteral nutrition.

Saravana P, Lau M, Dashti H Eur J Clin Nutr. 2024; .

PMID: 39580544 DOI: 10.1038/s41430-024-01548-z.


Nomogram for Predicting Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with Insulin Pump During Enteral Nutrition.

Wu J, Wu J, Zhou Y, Lu X, Zhao W, Xu F Diabetes Metab Syndr Obes. 2024; 17:2147-2154.

PMID: 38827166 PMC: 11141570. DOI: 10.2147/DMSO.S436390.


Novel Automated Self-adjusting Subcutaneous Insulin Algorithm Improves Glycemic Control and Physician Efficiency in Hospitalized Patients.

Mehta P, Kohn M, Rov-Ikpah E, San Luis C, Johnson C, Lee G J Diabetes Sci Technol. 2024; 18(3):541-548.

PMID: 38454631 PMC: 11089873. DOI: 10.1177/19322968241232673.


High carbohydrate is preferable to high lipid parenteral nutrition in healthy dogs undergoing prolonged sedation.

Regalin D, de Moraes R, Adorno B, Comassetto F, da Costa Regalin B, Gehrcke M Vet Res Commun. 2024; 48(2):1171-1187.

PMID: 38231371 DOI: 10.1007/s11259-024-10304-4.


References
1.
Anderson A, Palmer D, MacFie J . Peripheral parenteral nutrition. Br J Surg. 2003; 90(9):1048-54. DOI: 10.1002/bjs.4328. View

2.
Sajbel T, Dutro M, Radway P . Use of separate insulin infusions with total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1987; 11(1):97-9. DOI: 10.1177/014860718701100197. View

3.
Askanazi J, Weissman C, Rosenbaum S, HYMAN A, Milic-Emili J, Kinney J . Nutrition and the respiratory system. Crit Care Med. 1982; 10(3):163-72. DOI: 10.1097/00003246-198203000-00005. View

4.
Valero M, Leon-Sanz M, Escobar I, Gomis P, de la Camara A, Moreno J . Evaluation of nonglucose carbohydrates in parenteral nutrition for diabetic patients. Eur J Clin Nutr. 2002; 55(12):1111-6. DOI: 10.1038/sj.ejcn.1601274. View

5.
Bienso R, Ringholm S, Kiilerich K, Aachmann-Andersen N, Krogh-Madsen R, Guerra B . GLUT4 and glycogen synthase are key players in bed rest-induced insulin resistance. Diabetes. 2012; 61(5):1090-9. PMC: 3331744. DOI: 10.2337/db11-0884. View